TheFascination@beehaw.org to Science@beehaw.orgEnglish · edit-21 year agoEli Lilly drug shown to slow Alzheimer’s progressionarstechnica.comexternal-linkmessage-square6fedilinkarrow-up119arrow-down10cross-posted to: news@lemmy.worldtechnology@lemmy.worldtechnology@chat.maiion.comtechnology@lemmy.world
arrow-up119arrow-down1external-linkEli Lilly drug shown to slow Alzheimer’s progressionarstechnica.comTheFascination@beehaw.org to Science@beehaw.orgEnglish · edit-21 year agomessage-square6fedilinkcross-posted to: news@lemmy.worldtechnology@lemmy.worldtechnology@chat.maiion.comtechnology@lemmy.world
minus-squareTheOakTree@beehaw.orglinkfedilinkEnglisharrow-up1·edit-21 year agohttps://jamanetwork.com/journals/jama/fullarticle/2807533 May or may not be exactly what you were looking for, did not confirm lol
minus-squareDee@beehaw.orglinkfedilinkEnglisharrow-up1·1 year agoFrom the Ars Article: The donanemab trial involved 1,736 participants From your link: Findings In this randomized clinical trial that included 1736 participants with early symptomatic Alzheimer disease and… I would be VERY surprised if this wasn’t the study in question 😂 Thank you for finding that! I’ll read that over more when I get some time later!
minus-squareTheOakTree@beehaw.orglinkfedilinkEnglisharrow-up1·1 year agoNow imagine if it were coincidence… Thankfully it’s not. Happy to see that alzheimer research is getting more interest though, it’s a scary condition.
https://jamanetwork.com/journals/jama/fullarticle/2807533
May or may not be exactly what you were looking for, did not confirm lol
From the Ars Article:
From your link:
I would be VERY surprised if this wasn’t the study in question 😂
Thank you for finding that! I’ll read that over more when I get some time later!
Now imagine if it were coincidence…
Thankfully it’s not. Happy to see that alzheimer research is getting more interest though, it’s a scary condition.